Kura Oncology, Inc. (KURA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 910.95M |
| Enterprise Value | 782.31M |
| P/E Ratio | -3.53 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 13.67 |
| Price/Book Ratio | 21.81 |
| Enterprise/Revenue | 13.08 |
| Enterprise/EBITDA | -3.45 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -3.84 |
| Operating Margin | -4.12 |
| Return On Assets | -0.5 |
| Return On Equity | -2.07 |
| Revenue | 67.48M |
| Revenue/Share | 0.87 |
| Gross Profit | 67.43M |
| EBITDA | -275.83M |
| Net Income | -278.67M |
| Diluted EPS | -3.18 |
| Total Cash | 519.03M |
| Total Cash/Share | 5.84 |
| Total Debt | 24.46M |
| Total Debt/Equity | 0.5 |
| Current Ratio | 4.73 |
| Book Value Per Share | 0.55 |
| 52-Week Change | 55.42 |
| 52-Week High | 12.9 |
| 52-Week Low | 7.36 |
| Moving Average 50 Days | 10.47 |
| Moving Average 200 Days | 9.68 |
| Average Volume | 1.76M |
| Shares Outstanding | 88.77M |
| % Held by Institutions | 98.78 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |